Stilla Technologies with Source BioScience brings advanced genomics solutions to the UK market

Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source BioScience, a leading UK-based genomics service provider.

How a for-profit health system’s push to expand ended in disappointment for a tiny island nation

Protesters in the tiny Mediterranean nation of Malta converged last October on the 18th-century Baroque palace housing the prime minister’s offices chanting “thieves,” and unfurled a

March 22, 2024

A long-awaited update on anxiety and antidepressants

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Too much news to include below, but

January 31, 2025

Ultragenyx preps for pivotal trial in Angelman syndrome, an area where others fell short: #AAN24

Ultragenyx is inching closer to a Phase 3 study for its Angelman syndrome program, known as GTX-102. In a Phase 1/2 update Monday morning ahead

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.